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The global pandemic caused by the novel severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) has 
had a dramatic impact upon all areas of healthcare, and 
this is no more evident than in critical care. Management 
of the critically ill evolved over time, with variability in 
admission criteria and the use of invasive ventilation 
reported from around the world and within individual 
countries [1]. However, the majority of patients admitted 
to intensive care units (ICUs) required advanced respira-
tory support [1], often for longer periods than expected 
when compared with historical viral pneumonias [2]. 
Tracheostomy is an entrenched element of modern criti-
cal care, with the dominant indication established as 
facilitating long-term ventilation and ‘weaning’ from res-
piratory support. Additional indications include actual 
or threatened upper airway obstruction, facilitating pul-
monary clearance and to offer a degree of ‘protection’ 
against pulmonary aspiration. Prior to this pandemic, 
tracheostomy could be anticipated in 8–13% of patients 
receiving advanced respiratory support in modern ICUs 
[3]; usually temporary, but often in situ for several weeks 
(a median of 28 days in one recent UK-wide study) [4]. 
Reported rates of tracheostomies utilized during the 
coronavirus pandemic vary significantly from 16% to 61% 
[5, 6], but are certainly significantly higher than pre-pan-
demic rates.
As with many aspects of management, our under-
standing of how best to employ tracheostomy during 
the pandemic has evolved. There are many potential 
benefits of tracheostomy for the patient and for stressed 
healthcare systems, which have led some institutions to 
employ tracheostomy relatively early in the patient’s ICU 
stay, but detailed outcome data from large case series 
are not available. Tracheostomy insertion and subse-
quent management also requires trained, equipped and 
supported staff to minimize the potential for complica-
tions and patient safety incidents [7]. It is essential that 
we understand which patients with coronavirus disease 
2019 (COVID-19) may benefit from tracheostomy, along 
with when and how it should be employed. Importantly, 
in non-COVID-19 patients, only around 20% of trache-
ostomy patients survive beyond ICU discharge to 1 year 
[8], repeatedly raising questions about patient selection, 
which are relevant as hospitals around the world struggle 
to manage large volumes of critically ill patients. These 
problems are compounded in the pandemic with patients 
frequently managed in makeshift or unfamiliar settings, 
often by non-CU trained medical, nursing and allied 
healthcare professional staff.
In this state-of-the-art review, we consider these 
important issues affecting around one-fifth of critically ill 
patients presenting to our ICUs with severe respiratory 
failure resulting from COVID-19.
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Why perform a tracheostomy?
Tracheostomy can benefit patients who require pro-
longed ventilation: enabling sedation to be reduced or 
stopped; enabling the removal of the trans-laryngeal 
tube to facilitate laryngeal rehabilitation; and offer-
ing an interface for variable invasive ventilator support 
without having to resort to re-sedation and tracheal 
re-intubation [9]. Considering that patients with 
COVID-19 typically have longer periods of ventilation 
than patients with other viral pneumonias [2], it is not 
surprising that studies have demonstrated that trache-
ostomy for COVID-19 disease may confer a survival 
benefit [5], aid weaning from ventilatory support [6], 
and may ease the burden upon critical care resources 
[10]. Recent UK data highlighted that non-COVID-19 
tracheostomy patients typically spend a median of 50 
days in hospital, 28 days with a tracheostomy in situ, 
and 23 days within the ICU [4]. It is easy to appreciate 
how critical care resources may become overwhelmed 
following a surge in demand. When resources become 
stretched, decisions regarding resource allocation 
become more challenging, and difficult judgments bal-
ancing tracheostomy, prolonged ventilation, rehabili-
tation and the potential of providing a real benefit for 
long-term quality of life need to be made.
What makes a patient with COVID-19 different when 
considering tracheostomy? With the high transmissibility 
and risk of serious illness, the potential risks to health-
care staff need to be considered in addition to the poten-
tial benefits to the patient. One argument surrounds the 
challenges of primary extubation, with higher rates of 
reintubation reported in patients with COVID-19 [11]. 
Prolonged periods of tracheal intubation associated with 
the use of neuromuscular blocking agents [2] and the 
routine use of systemic corticosteroids [12] contribute 
to respiratory muscle deconditioning [13], which can 
make going straight from an endotracheal tube to self-
supported breathing challenging. Urgent re-intubation of 
a critically hypoxic patient has clear risks for the patient, 
but it is also important to consider the risks to attend-
ing staff. Non-invasive ventilation, face-mask continuous 
positive airway pressure, or high-flow nasal oxygen pose 
potential risks to healthcare staff through infectious aero-
sol generation [14], compounded by the risks associated 
with re-intubation [15].
SARS-CoV-2 itself may contribute to the increased 
rates of laryngeal edema and pathology reported in 
patients with COVID-19 [16, 17]. It is difficult to dis-
tinguish whether laryngeal pathology is a consequence 
of coronavirus infection, a sequel to the associated pro-
longed tracheal intubation, ventilation, prone position-
ing, and re-intubation, or more likely a combination of 
these direct and indirect factors [16–18].
An elective tracheostomy can provide a closed res-
piratory circuit to facilitate weaning (when used with an 
inflated tube cuff), allowing for a more controlled wean 
than an attempt at primary extubation considered at high 
risk of failure. However, tracheostomy care still requires 
airway interventions that may be considered aerosol-
generating and tracheostomy is not recommended in 
patients who are likely to require management in the 
prone position [19].
In addition to benefits for patients and staff, tra-
cheostomy may also provide additional logistical and 
resource benefits for the hospital [20]. Patients with a 
tracheostomy typically require reduced or no sedation, 
reducing resource pressures on drugs, equipment and 
monitoring [21] and allowing for less intensive nurs-
ing care, as the patient may be able to assist in their own 
movement and self-care and be less dependent on mul-
tiple staff for re-positioning. During the pandemic, with 
increased demand for critical care beds compounded by 
staff absence through illness or shielding, there has been 
a reliance on non-critical care nurses and other health-
care professionals to assist within the ICU. Tracheos-
tomy patients may be easier to care for than fully sedated 
patients, but adequate training must be undertaken to 
ensure these healthcare professionals are able to manage 
tracheostomies and identify any potential complications 
[22] and a role for nursing specialties already experienced 
with tracheostomies (head and neck surgery for example) 
may be beneficial.
It remains essential that the potential benefits of a tra-
cheostomy are weighed against the potential burden for 
patients and risks to staff and local critical care resources. 
Tracheostomy should only be considered in patients 
recovering from critical illness who have a good chance 
of making a meaningful recovery.
When to perform a tracheostomy?
Tracheostomies can pose a risk for the patient and the 
staff both in terms of insertion and subsequent manage-
ment and, thus, the first priority when considering opti-
mal timing for tracheostomy is whether the procedure 
will benefit the patient. Exposing the patient and staff to 
procedural risks when the patent is unlikely to survive 
does not benefit anybody. However, predicting which 
patients might benefit is difficult, both within and outside 
of the pandemic period. Considering that tracheostomy 
is indicated in those patients who have difficulty breath-
ing and coughing independently, it is no surprise that 
mortality rates are high during critical illness and follow-
ing ICU or hospital discharge [8]. Tracheostomies should 
only be undertaken in patients who are clinically improv-
ing. Patients requiring (or likely to require) prone posi-
tioning for respiratory failure should not be considered 
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for tracheostomy due to the increased risk of tube dis-
placement, occlusion, or impaired ability to identify tra-
cheostomy-related complications in the prone position 
[23]. As with all complex decisions, a multidisciplinary 
approach is recommended [22].
Optimal timing for tracheostomy remains controversial 
in non-COVID-19 patients [24] and becomes more com-
plicated in patients with COVID-19 due to the perceived 
risk of aerosol generation. Virological evidence suggests 
that the viral load falls from a peak associated with the 
onset of symptoms, although the window of detection is 
prolonged in critical illness [19] (Fig. 1). Considering that 
the insertion procedure is aerosol generating, therefore 
posing risks to operators and attending staff, delaying 
tracheostomy is likely to benefit staff by reducing the risk 
of transmission [25, 26]. This must be balanced against 
the potential benefits to the patient of early tracheos-
tomy, such as reducing laryngeal injury and laryngeal 
dysfunction associated with prolonged tracheal intuba-
tion, reducing the cumulative burden of sedative agents, 
and promoting pulmonary hygiene through better secre-
tion clearance [27–29]. Earlier tracheostomy also allows 
for outcomes that patients find particularly important, 
such as an earlier return to eating, drinking, talking, and 
engaging in proactive rehabilitation [30–32]. The factors 
favoring early or late tracheostomy in patients suffering 
from COVID-19 disease are summarized in Fig. 2.
Early in the evolution of the pandemic, healthcare 
workers were rightly concerned about the risks of trans-
mission during the tracheostomy insertion procedure, 
which has the potential to generate infectious aero-
sols. While many organizations in different countries 
advocated a cautious and therefore delayed approach 
to tracheostomy, a review of 26 international protocols 
demonstrated that timing for tracheostomy in COVID-
19 varied from 3 to > 21  days [33]. The majority of 
Severe disease with progression; median time of death, 21 days from onset
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Fig. 1 Typical clinical course, viral polymerase chain reaction (PCR), and antiviral antibody detection and infectivity of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) infection. The transparent red box shows the suggested window for tracheostomy, on ICU days 10–21, which 
corresponds with 16–30 days from symptom onset. The solid bars and curves represent the proportion of all cases. Time zero is symptom onset (the 
x-axis is not to scale). Adapted from [19] with permission
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protocols considered the implied infectivity of the criti-
cally ill patient, and as the predicted viral load and anti-
body response became more precisely characterized as 
the pandemic unfolded, most recommended a minimum 
of 14  days of mechanical ventilation prior to tracheos-
tomy, balancing the risks of patient benefit with risks 
to staff (Fig.  3). As staff became more confident with 
personal protective equipment (PPE) and in managing 
patients with severe COVID-19, reports emerged indi-
cating a role for early tracheostomy in some patients, 
with potential mortality benefits [5]. Although case selec-
tion for early tracheostomy will remain an evolving chal-
lenge, what is clear is that the timing of tracheostomy in 
the management of severe COVID-19-associated respira-
tory failure is returning to ‘business as usual’ [23].
The question of whether the patient is physiologically 
stable enough to tolerate the tracheostomy insertion 
is very relevant, as the time to discover that the patient 
will desaturate rapidly when ventilation is suspended 
is not when the neck has just been opened. Physiologi-
cal deterioration can be anticipated to some degree in 
all tracheostomy procedures due to inadequate ventila-
tion, transient suspension of ventilation and the lung 
de-recruitment associated with exchanging the trans-
laryngeal tube for a new tracheostomy. However, the 
deranged respiratory physiology associated with severe 
COVID-19 may cause an exaggerated deterioration if the 
patient has not recovered sufficient physiological reserve 
to tolerate the procedure. An international expert panel 
suggested a pre-procedural ‘apnea test’ which attempts 
to simulate the procedural conditions and thus predict 
physiological readiness. Pre-oxygenation, followed by a 
trial of apnea in the ICU, with a FiO2 of 1. 0 and posi-
tive end-expiratory pressure (PEEP) of 5 cmH2O in the 
supine patient is suggested [19]. Rapid desaturation pre-
dicts a similar response during tracheostomy, indicating 
risk to the patient (and also to staff who may be required 
to undertake unplanned or additional airway interven-
tions). Tracheostomy should be deferred in these circum-
stances. Importantly, the ability to conduct or tolerate an 
apnea trial should not replace multidisciplinary clinical 
judgement regarding the risks and benefits of undertak-
ing tracheostomy in a given patient at a particular time 
[34].
What is the best technique for inserting 
a tracheostomy?
The first consideration is location. Performing the proce-
dure in the ICU minimizes patient movement, avoids the 
logistical considerations of assembling an operating room 
team, but brings technical obstacles such as the large 
ICU bed and deficiencies in trained assistance, the envi-
ronment, and with equipment (Table 1). Ideally, aerosol-
generating procedures in potentially infectious patients 
Early tracheostomy Late tracheostomy
Clinically unstable
Ventilator associated muscle wasting




Early engagement with rehabilitation
Risk of COVID-19 transmission during
peocedure
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Fig. 2 Factors favoring early or late tracheostomy in patients with COVID-19 disease. Patient factors (blue), staff factors (paler blue) and critical care 
resource factors (brown). Adapted from [19] (with permission)
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should occur in negative pressure isolation rooms. These 
are not universally available, but conditions are probably 
most closely replicated in the operating room suite [35].
Second, the choice of insertion technique is essentially 
between an open surgical or a percutaneous approach. 
Hybrid approaches have been described and there are 
variations in all techniques described in the literature 
and facilitated by a wide range of equipment. An open 
technique was favored during the earlier severe acute 
respiratory syndrome (SARS), Middle East respiratory 
syndrome (MERS) and Avian influenza A (H5N1) viral 
pandemics based on low reported rates of transmission 
to operators [36, 37]. However, percutaneous techniques 
have progressed substantially in the last 20  years and 
Fig. 3 Balancing the benefit to the patient versus the risk to the staff
Table 1 Advantages and disadvantages of performing a tracheostomy in the intensive care unit or operating room
Intensive care unit Operating room
Advantages Disadvantages Advantages Disadvantages
No transfer Positioning can be Support available Requires patient transfer
required difficult Controlled (aerosol) (exposure risks to patient,
Timely (not Less equipment environment staff and others)
dependent on available for Typically performed Requires a surgeon to be
operating rooms) complications by surgeons (may save available
Convenient for Fewer resources in ICU resources) Takes an operating slot
ICU team the event of a complication Good lighting
Suboptimal lighting
Potential for distractions
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many single centers have reported successful percuta-
neous approaches during the current pandemic, with 
apparently low rates of infectivity among attending staff 
[38–40].
The relative risks and benefits of percutaneous or sur-
gical approaches have been debated in the literature for 
many years. Perceived benefits to the percutaneous tech-
nique are: familiarity to critical care staff; reduced air 
leak from the smaller stoma; fewer wound infections; and 
reduced bleeding complications.
However, percutaneous approaches involve: more air-
way manipulation than a surgical procedure; withdrawal 
of the tracheal tube risking extubation and aerosol gen-
eration; and, when combined with endoscopic visuali-
zation, may result in inadequate ventilation, significant 
upper airway gas leak and aerosol generation during the 
procedure. Perceived advantages to an open surgical 
technique relevant to COVID-19 are that it allows for 
a more controlled procedure, performed under direct 
vision. When combined with an expert anesthesiolo-
gist manipulating the tracheal tube in an ideal operating 
room environment, a surgical procedure may be safer.
Third, there may be situations where the patient’s con-
dition favors a particular approach. Difficult neck anat-
omy, obesity or overlying thyroid gland or vessels are 
established indications for a surgical approach. What 
is less clear is how to manage patients who are receiv-
ing anticoagulants, receiving antiplatelet medication, or 
who are at an increased risk of bleeding—all of which are 
common dilemmas during the coronavirus pandemic. A 
percutaneous approach involves less dissection, a smaller 
stoma and thus a tamponading effect from the newly 
inserted tube, which may reduce post-procedural bleed-
ing. A surgical approach offers more direct access to 
control specific bleeding sources, although the use of dia-
thermy may be implicated in aerosolizing viral particles 
and diathermy should be kept to a minimum [19].
Fourth, modifications and considerations have been 
proposed to help reduce the risk of aerosol generation 
during tracheostomy insertion. Most advocate suspend-
ing ventilation at key steps in the insertion process: 
manipulation of the tracheal tube within the upper air-
way; opening the trachea; any dilatation of the stoma; 
and during insertion of the new tracheostomy tube [41]. 
This period of apnea, however brief, risks significant 
de-recruitment and hypoxia, and a period of pre-oxy-
genation can help mitigate this. During a surgical inser-
tion, the tracheal tube with the balloon inflated may be 
advanced distally within the trachea beyond the trache-
otomy, thus keeping the breathing circuit ‘closed’ [42]. 
Clear communication between all team members is 
essential. Communication may be impeded by PPE and 
planning, rehearsal, and simulated practice are recom-
mended [19]. It is also recommended that the patient 
should be paralyzed, thus preventing coughing and 
unwanted movement and reducing peak airway pressures 
[19, 41].
Finally, the logistics of managing multiple critically 
ill patients in our hospitals may influence the choice of 
technique simply through the availability of trained staff 
to undertake the procedure, with many centers report-
ing a significant rise in the number of surgical procedures 
undertaken during the pandemic [23, 39–42].
Because of the aerosol-generating nature of this proce-
dure, it is imperative that appropriate PPE is always worn 
by whoever undertakes the tracheostomy insertion, and 
only essential staff are present in the immediate environ-
ment [36]. What is clear is that more research is needed 
to understand the optimal technique for a particular set 
of circumstances and while we await clearer answers, 
practitioners are advised to do what works best in their 
institution, with their local resources, practice and exper-
tise used optimally following multidisciplinary discussion 
between all stakeholders.
Subsequent management of a patient 
with a tracheostomy
For patients with COVID-19 who have a tracheostomy, 
the aims of care are to minimize airway interventions 
and potential aerosol generation, whilst maintain-
ing standards of safe care and ensuring that patients 
are proactively rehabilitated. All interventions should 
involve thorough planning to reduce risks to both 
patients and staff, and care should be performed by staff 
experienced with tracheostomy care [22]. Strategies 
to minimize aerosol production have been proposed, 
which include reducing ‘routine’ suction and inner 
cannula care to a minimum [43], using ‘closed suction’ 
systems, and using heat and moisture exchange (HME) 
filters in ventilator circuits instead of heated water-
based ‘active’ humidification systems [44]. All of these 
strategies require regular review for each patient. If, for 
example, secretions become thicker, additional thera-
pies such as mucolytic drugs, nebulizers, or switching 
to active humidification may be required [19].
It is recognized that tracheostomy weaning in a 
patient with COVID-19 provides a unique challenge. In 
non-COVID-19 patients, the process of weaning would 
involve gradually decreasing the ventilatory support 
alongside periods of cuff deflation, strategies which 
clearly promote aerosol generation [43, 45]. A ‘cuff-up’ 
strategy is initially suggested for patients with COVID-
19 disease, and only when the patient is deemed at 
lower risk of infectivity should the cuff be deflated 
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[18]. Others have argued that this cautious approach 
disadvantages patients and may slow their recovery 
and laryngeal rehabilitation, instead advocating for 
adequate staff PPE in dedicated clinical areas along-
side face and tracheostomy shields to reduce aerosol 
risks [19]. The optimal strategy is yet to be determined, 
but will be heavily influenced by local infrastructure, 
the environment and the experience and confidence of 
attending staff.
The deep psychological impact of an ICU stay on 
patient wellbeing during and beyond the ICU is well 
documented [46]. However, COVID-19 has posed new 
challenges by limiting the interactions that patients can 
have with family and staff. Speech for patients with a 
tracheostomy usually requires cuff deflation, risk-
ing aerosolization if positive pressure ventilation or 
ventilatory support is still required. Innovative com-
munication methods include communication boards, 
‘speaking’ tracheostomy tubes, above-cuff vocalization 
strategies, the use of an electrolarynx and other alter-
native communication devices [47]. Oral feeding, fol-
lowing a rigorous swallow assessment may also provide 
psychological benefit [32]. Such patient-focused out-
comes are highlighted in Fig. 4.
Safe decannulation should occur as soon as clini-
cally possible [19]. Some have argued that decannula-
tion should occur only following negative COVID-19 
test results [48], but this may not be feasible if intensive 
care beds are limited, especially as complete viral clear-
ance may take a significant period of time [49], thus 
delaying necessary patient care.
Conclusion
Tracheostomy is an important therapeutic intervention 
in the critically ill. The coronavirus pandemic has seen 
a significant increase both in the proportion of criti-
cally ill patients who become tracheostomy candidates 
and the absolute numbers of patients undergoing tra-
cheostomy. Decisions surrounding candidacy, optimal 
timing, optimal technique and the optimal multidisci-
plinary aftercare of tracheostomies in the critically ill 
can be complex outside of the pandemic—a situation 
made yet more complex by the potential to transmit 
disease by infectious aerosols from those with COVID-
19. After a steep learning curve, our multidisciplinary 
community is well placed to protect healthcare staff 
while ensuring that the best possible, pro-active care 
is delivered to the many patients who will benefit from 
tracheostomy as part of their critical illness manage-
ment. Many questions remain, and continued tra-
cheostomy research, global collaboration and quality 
improvement is imperative [50] to ensure the bounda-
ries of quality tracheostomy care continue to be pushed 
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Fig. 4 Patient-focused outcomes in tracheostomy care (the patient provided permission to publish the photo)
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